Jennifer Morganroth

Affiliations

Department of Neurology (JM, LZ, GTL, SJB, AGH), Perelman School of Medicine, University of Pennsylvania, Philadelphia; Division of Neuromuscular Medicine (ACG), Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston; Department of Ophthalmology (GTL, AGH); Division of Thoracic Surgery (SS), Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia; Department of Neurology (GIW), Jacobs School of Medicine and Biomedical Sciences, State University at Buffalo/SUNY, NY; and Department of Biostatistics, Epidemiology, and Informatics (AGH), Perelman School of Medicine, University of Pennsylvania, Philadelphia.

ORCID: https://orcid.org/0000-0001-9696-5306

Publications (5)

Trends and Disparities in the Utilization of Thymectomy for Myasthenia Gravis in the United States.

Neurology. Clinical practice

Avec: Jennifer Morganroth , Leah Zuroff , Amanda C Guidon , Grant T Liu , Shawn J Bird , Sunil Singhal , Gil I Wolfe , Ali G Hamedani

Enhancing Clinical Infrastructure for the Delivery of Intrathecal and Genetic Therapies: A Qalsody (Tofersen) Model for Patients With

Neurology. Clinical practice

Avec: Jennifer Morganroth , Tanya M Bardakjian , Laynie Dratch , Colin C Quinn , Lauren B Elman

QT effects of bedaquiline, delamanid, or both in patients with rifampicin-resistant tuberculosis: a phase 2, open-label, randomised, controlled trial.

The Lancet. Infectious diseases

Avec: Kelly E Dooley , Susan L Rosenkranz , Francesca Conradie , Laura Moran , Richard Hafner , Florian von Groote-Bidlingmaier , Javier R Lama , Justin Shenje , Jorge De Los Rios , Kyla Comins , Joel Morganroth , Andreas H Diacon , Yoninah S Cramer , Kathleen Donahue , Gary Maartens , Auteur inconnu

A Thorough QT/QTc Study With Laquinimod, a Novel Immunomodulator in Development for Multiple Sclerosis and Huntington Disease.

Clinical pharmacology in drug development

Avec: Ofer Spiegelstein , Dorit Mimrod , Laura Rabinovich , Eli Eyal , Craig Sprenger , Anna Elgart , Emil Samara , Joel Morganroth

Assessing Prolongation of the Corrected QT Interval with Bedaquiline and Delamanid Coadministration to Predict the Cardiac Safety of Simplified Dosing Regimens.

Clinical pharmacology and therapeutics

Avec: Lénaïg Tanneau , Mats O Karlsson , Susan L Rosenkranz , Yoninah S Cramer , Justin Shenje , Caryn M Upton , Joel Morganroth , Andreas H Diacon , Gary Maartens , Kelly E Dooley , Elin M Svensson

Réseau de co-auteurs

Joel Morganroth 3 collaborations

Kelly E Dooley 2 collaborations

Susan L Rosenkranz 2 collaborations

Justin Shenje 2 collaborations

Andreas H Diacon 2 collaborations

Yoninah S Cramer 2 collaborations

Gary Maartens 2 collaborations

Leah Zuroff 1 collaboration

Amanda C Guidon 1 collaboration

Grant T Liu 1 collaboration

Shawn J Bird 1 collaboration

Sunil Singhal 1 collaboration

Gil I Wolfe 1 collaboration

Ali G Hamedani 1 collaboration

Tanya M Bardakjian 1 collaboration

Laynie Dratch 1 collaboration

Colin C Quinn 1 collaboration

Lauren B Elman 1 collaboration

Francesca Conradie 1 collaboration

Laura Moran 1 collaboration

Richard Hafner 1 collaboration

Florian von Groote-Bidlingmaier 1 collaboration

Javier R Lama 1 collaboration

Jorge De Los Rios 1 collaboration

Kyla Comins 1 collaboration

Kathleen Donahue 1 collaboration

None None 1 collaboration

Ofer Spiegelstein 1 collaboration

Dorit Mimrod 1 collaboration

Laura Rabinovich 1 collaboration

Eli Eyal 1 collaboration

Craig Sprenger 1 collaboration

Anna Elgart 1 collaboration

Emil Samara 1 collaboration

Lénaïg Tanneau 1 collaboration

Mats O Karlsson 1 collaboration

Caryn M Upton 1 collaboration

Elin M Svensson 1 collaboration